Ubiquitin E3 Ligase A20 Facilitates Processing Microbial Product in Nasal Epithelial Cells
Open Access
- 1 October 2012
- journal article
- clinical trial
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 287 (42) , 35318-35323
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Staphylococcus aureus Colonization in Children With Community-Associated Staphylococcus aureus Skin Infections and Their Household ContactsArchives of Pediatrics & Adolescent Medicine, 2012
- Staphylococcal α-Toxin Induces a Higher T Cell Proliferation and Interleukin-31 in Atopic DermatitisInternational Archives of Allergy and Immunology, 2011
- Mucosal tissue polyclonal IgE is functional in response to allergen and SEBAllergy, 2010
- Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor–induced toxicity and experimental colitisJournal of Experimental Medicine, 2010
- RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studiesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- The zinc finger protein A20 targets TRAF2 to the lysosomes for degradationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2009
- FcRn-mediated antibody transport across epithelial cells revealed by electron tomographyNature, 2008
- Regulation of the V-ATPase along the Endocytic Pathway Occurs through Reversible Subunit Association and Membrane LocalizationPLOS ONE, 2008
- The Ubiquitin-Editing Enzyme A20 Restricts Nucleotide-Binding Oligomerization Domain Containing 2-Triggered SignalsImmunity, 2008
- TIM-4 Expressed by Mucosal Dendritic Cells Plays a Critical Role in Food Antigen–Specific Th2 Differentiation and Intestinal AllergyGastroenterology, 2007